Nicotine Polacrilex Lozenge
Product Images NDC 72162-2267

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 72162-2267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

This text provides a schedule for using lozenges as part of a step-down plan for smoking cessation. It indicates the frequency of lozenge use at different stages of the plan, including reminders to start at the beginning of weeks 1 and 7, with specific intervals between doses. Additionally, it suggests continuing the plan 12 weeks after the quit date, indicating a gradual reduction in lozenge use over time.*

FDA Label Image

Label (Lbl721622267)

This text contains information about nicotine lozenges as a stop smoking aid. It includes details on the active ingredient, purpose, directions for use, warnings, and other relevant product information. The text also lists the inactive ingredients, NDC number, and manufacturer details.*

FDA Label Image

Pic1 (Pic1)

This text provides a list of contact numbers for different organizations that can help with various health issues such as lung problems, cancer, and heart health. It also suggests seeking support from a friend who has quit smoking. This information is suitable for inclusion on a wallet card for quick access to help resources.*

FDA Label Image

Pic2 (Pic2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.